Drug
C 1101
C 1101: highest development phase Phase 1, developed by Consano Bio. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Consano Bio
Trials
| Drug | Phase | Indication |
|---|---|---|
| C-1101 NCT07264270 | Phase 1 | Lumbosacral Radicular Pain |
Latest
No recent events.
Follow C 1101 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.